SignalbaseUpdated 07 Sept 2026

Top recently funded startups in Switzerland, week of 2026-09-07

Switzerland logged 2 verified funding rounds in the week ending 06 Sept 2026, totalling ≈$32.0M. NovaGo Therapeutics anchors the week with a ≈$30.0M Series B in Hospitals and Health Care.

Week of 2026-09-07Switzerland2 deals≈$32.0M raised

Country	Switzerland
Deals this week	2
Total raised	≈$32.0M
Top sector	Hospitals and Health Care (1)
Most common round	Seed (1)
Sources tracked	12

The biggest 2 deals this week

#	Company	Amount	Round	Sector	Announced
1	NovaGo Therapeutics	$30.0M	Series B	Hospitals and Health Care	02 Sept 2026
2	KOVE medical Ltd	$2.0M	Seed	Manufacturing	31 Aug 2026

Closer look at the top 2

NovaGo Therapeutics

Announced 02 Sept 2026

$30.0M · Series B · Hospitals and Health Care · Switzerland

NovaGo’s fully human monoclonal antibodies have the potential to become a safe and effective treatment in central nervous system indications.

“🚨 NEWS ALERT: Swiss biotech NovaGo Therapeutics has raised $30 million in a Series B round to advance its lead anti-Nogo-A antibody into a randomized proof-of-concept study in patients with acute spinal cord injury. The financing was co-led by Neurimmune AG and Pureos Bioventures, with participation from existing and new investors.”
From the announcement · 02 Sept 2026

6 more sources tracked. Read the full press release and reporter coverage.

Investors: Neurimmune AG, Pureos Bioventures.

KOVE medical Ltd

Announced 31 Aug 2026

$2.0M · Seed · Manufacturing · Switzerland

Most active investors this week

#	Investor	Deals
1	Neurimmune AG	1
2	Pureos Bioventures	1

What this week tells us

Hospitals and Health Care accounted for 1 of 2 verified deals in Switzerland this week. The stage mix was 1 early-stage (pre-seed to seed) against 1 Series A or later.